Posttraumatic Stress Disorder (PTSD)
BASICS
- Definition: Psychiatric disorder after experiencing or witnessing traumatic events (death, sexual violence, serious injury, or threat thereof).
- Core Symptom Clusters: (≥1 month for diagnosis)
- Intrusion: Flashbacks, nightmares, distressing recollections
- Avoidance/Numbing: Avoid trauma reminders; emotional detachment
- Negative Alterations in Mood/Cognition: Amnesia, negative beliefs, detachment, inability to experience positive emotions
- Increased Arousal/Reactivity: Sleep disturbance, irritability, hypervigilance, concentration issues, self-destructive behavior
EPIDEMIOLOGY
- Incidence: ~7.7 million U.S. adults/year (3.5%)
- Lifetime prevalence: 6.8%
- Highest risk traumas: Unexpected death of loved one, rape, sexual assault
- 16% of trauma-exposed children/adolescents develop PTSD
ETIOLOGY & PATHOPHYSIOLOGY
- Biological: Catecholamine hypersensitivity, opioid pathway overactivity, amygdala/hippocampus dysfunction, serotonergic & glutamatergic dysregulation
- Learning Theory: Trauma cues → conditioned fear response (“fight-or-flight”)
- Cognitive/Psychodynamic: Persistent trauma memories overwhelm defenses, drive repeated recall
RISK FACTORS
- Pre-existing: Female sex, young age, psychiatric history, low SES
- Peritrauma: Severe trauma, intense emotional response, threat perception
- Posttrauma: Injury severity, complications, poor social support, persistent dissociation, further trauma exposure
GENERAL PREVENTION
- Trauma-focused CBT and prolonged exposure (delivered within weeks after trauma) best supported for prevention in distressed individuals.
COMMONLY ASSOCIATED CONDITIONS
- Adults: Depression, substance abuse, panic/social phobias, OCD, dementia, smoking (esp. after assault)
- Pediatrics: Oppositional defiant disorder, separation anxiety
DIAGNOSIS
DSM-5 Criteria
- A: Trauma exposure (direct, witnessed, learned about close other, or repeated exposure to details)
- B: Intrusion (≥1 symptom)
- C: Avoidance (≥1)
- D: Negative mood/cognition (≥2)
- E: Hyperarousal (≥2)
- F: Duration >1 month
- G: Clinically significant distress/functional impairment
- H: Not due to substance or medical illness
Pediatric Note:
- Separation fears, regressive behaviors, somatic complaints, school avoidance, nightmares, irritability
HISTORY & EXAM
- Symptoms: Intrusion, avoidance, mood/cognition changes, hyperarousal (>1 month)
- Exam: May see agitation, poor hygiene, altered affect, memory/concentration deficits, poor impulse control, somatic injury from trauma
- Pediatrics: Heart rate elevation after trauma may predict PTSD
DIFFERENTIAL DIAGNOSIS
- GAD, adjustment disorder, OCD, schizophrenia, depression/mood disorder, substance abuse, dissociative/personality disorders, malingering
- Primary Care PTSD Screen (PC-PTSD-5)
- Trauma Screening Questionnaire (TSQ)
TREATMENT
General Principles
- Best outcomes with psychotherapy + pharmacotherapy soon after trauma.
- CBT (trauma-focused/exposure): Gold standard; includes EMDR.
- Telemedicine/collaborative care: Effective in multiple settings.
Medication
First-Line (SSRIs)
- Sertraline: 50–200 mg daily (FDA-approved)
- Paroxetine: Start 10 mg, titrate up (FDA-approved)
- Fluoxetine: 20–80 mg/day
Sleep/Nightmares
- Trazodone 50–300 mg QHS
- Mirtazapine 7.5–30 mg QHS
- Amitriptyline 25–100 mg QHS
- Prazosin 2–15 mg QHS for nightmares
- Clonidine 0.1–0.2 mg QHS
Second-Line/Augmentation
- SNRIs: Venlafaxine, duloxetine, desvenlafaxine
- Mirtazapine: 15–45 mg/day
- Antipsychotics: Aripiprazole, risperidone, olanzapine, quetiapine (for intrusive thoughts, hyperarousal)
- Alpha-agonists: Clonidine, guanfacine (hyperarousal)
- Mood stabilizers: Valproic acid, carbamazepine, topiramate (impulsivity)
- Anxiety: Hydroxyzine or (rarely) risperidone PRN (avoid benzodiazepines)
Children:
- Little evidence for medication; focus on therapy.
ONGOING CARE
- Long-term therapy: May be needed, especially in complex PTSD/childhood sexual abuse.
- Monitor for retraumatization, comorbidities.
- Parent PTSD is a strong predictor of pediatric PTSD.
- Education: National Center for PTSD—https://www.ptsd.va.gov
PROGNOSIS
- 50% remit in 3 months; others have persistent/life-long impairment.
- Better outcomes: Early treatment, good support, avoidance of retraumatization, absence of comorbidities
COMPLICATIONS
- Increased risk for panic/social/OCD, depression, suicide, homicide, substance abuse
- Sexual assault survivors are at especially high risk for severe sequelae
ICD-10 CODES
- F43.10 Post-traumatic stress disorder, unspecified
- F43.11 PTSD, acute
- F43.12 PTSD, chronic
CLINICAL PEARLS
- Combined psychotherapy and pharmacotherapy is most effective.
- Exposure-based therapies (CBT, EMDR) have highest evidence.
- SSRIs are first-line medications.
- Avoid benzodiazepines due to poor efficacy and risk of misuse.
- Pediatric PTSD is common—parental stress must be addressed.